The functional consequences of sodium channel NaV 1.8 in human left ventricular hypertrophy

ESC Heart Fail. 2019 Feb;6(1):154-163. doi: 10.1002/ehf2.12378. Epub 2018 Oct 30.

Abstract

Aims: In hypertrophy and heart failure, the proarrhythmic persistent Na+ current (INaL ) is enhanced. We aimed to investigate the electrophysiological role of neuronal sodium channel NaV 1.8 in human hypertrophied myocardium.

Methods and results: Myocardial tissue of 24 patients suffering from symptomatic severe aortic stenosis and concomitant significant afterload-induced hypertrophy with preserved ejection fraction was used and compared with 12 healthy controls. We performed quantitative real-time PCR and western blot and detected a significant up-regulation of NaV 1.8 mRNA (2.34-fold) and protein expression (1.96-fold) in human hypertrophied myocardium compared with healthy hearts. Interestingly, NaV 1.5 protein expression was significantly reduced in parallel (0.60-fold). Using whole-cell patch-clamp technique, we found that the prominent INaL was significantly reduced after addition of novel NaV 1.8-specific blockers either A-803467 (30 nM) or PF-01247324 (1 μM) in human hypertrophic cardiomyocytes. This clearly demonstrates the relevant contribution of NaV 1.8 to this proarrhythmic current. We observed a significant action potential duration shortening and performed confocal microscopy, demonstrating a 50% decrease in proarrhythmic diastolic sarcoplasmic reticulum (SR)-Ca2+ leak and SR-Ca2+ spark frequency after exposure to both NaV 1.8 inhibitors.

Conclusions: We show for the first time that the neuronal sodium channel NaV 1.8 is up-regulated on mRNA and protein level in the human hypertrophied myocardium. Furthermore, inhibition of NaV 1.8 reduced augmented INaL , abbreviated the action potential duration, and decreased the SR-Ca2+ leak. The findings of our study suggest that NaV 1.8 could be a promising antiarrhythmic therapeutic target and merits further investigation.

Keywords: Arrhythmias; Calcium; HFpEF; Late sodium current; Left ventricular hypertrophy; SR-Ca2+ leak; Sodium channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Aged
  • Blotting, Western
  • Diastole
  • Female
  • Gene Expression Regulation*
  • Heart Ventricles / metabolism*
  • Heart Ventricles / pathology
  • Heart Ventricles / physiopathology
  • Humans
  • Hypertrophy, Left Ventricular / diagnosis
  • Hypertrophy, Left Ventricular / genetics*
  • Hypertrophy, Left Ventricular / metabolism
  • Male
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology
  • NAV1.8 Voltage-Gated Sodium Channel / biosynthesis
  • NAV1.8 Voltage-Gated Sodium Channel / genetics*
  • Patch-Clamp Techniques
  • RNA / genetics*
  • Real-Time Polymerase Chain Reaction
  • Sarcoplasmic Reticulum / metabolism

Substances

  • NAV1.8 Voltage-Gated Sodium Channel
  • SCN10A protein, human
  • RNA